BCRN Management Committee

Recognizing the need to more aggressively engage the research community, BCAN created a new division in our organization, BCRN–the Bladder Cancer Research Network—which is the cornerstone of our research mission.  This new division is led by a Management Committee, comprised of leading doctors and scientists representing all aspects of bladder cancer research, including urology, medical oncology, basic science, pathology, radiation oncology and population science.

 

Hikmat Al-Ahmadie, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York

Jessie Au, Pharm.D., PhD
Optimum Therapeutics
San Diego, CA

Dean F. Bajorin, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York

Robert Dreicer M.D., MS
University of Virginia
Charlottesville, VA

David M. Latini, PhD
Baylor College of Medicine
Houston, Texas

Seth Lerner, M.D., FACS
Baylor College of Medicine
Houston, Texas

Yair Lotan, M.D.
UT Southwestern Medical Center
Dallas, Texas

David J. McConkey, M.D., PhD.
M.D. Anderson Cancer Center
Houston, Texas

Matthew I. Milowsky, M.D.
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina

William U. Shipley, M.D., FACR
Harvard Medical School and Massachusetts General Hospital
Cambridge and Boston, Massachusetts

Eila Skinner, MD
Stanford University

John A. Taylor, III, MD, MS
University of Connecticut
Farmington, Connecticut

Diane Zipursky Quale
BCAN President
Bethesda, Maryland

Gary D. Steinberg, M.D., FACS (Ex-offico)
University of Chicago
Chicago, Illinois

Colin P.N. Dinney, M.D. (Ex-officio)
MD Anderson Cancer Center
Houston, Texas

 

 

 

 

Share this page:Share on FacebookTweet about this on TwitterShare on Google+Share on TumblrShare on LinkedInEmail this to someone

GO TO TOP ^
This website is supported by a generous grant from Photocure
SITE DESIGN: GALANTI DESIGN